MB ,,Biovala labs" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 2,665 |
| - |
| -600 |
| -600 |
| - |
| 100.00 |
| -22.51 |
| -533 |
| 1,054 |
| 0 |
| 521 |
| -0.20 |
| -1.98 |
| - |
| - |
| -22.51 |
| -600 |
| 2024 |
|---|
| 2,990 |
| 2,990 |
| -875 |
| -875 |
| -875 |
| 29.43 |
| -29.26 |
| -1,408 |
| 1,467 |
| 0 |
| 59 |
| -0.47 |
| -1.04 |
| - |
| - |
| -29.26 |
| -875 |
| 2025 |
|---|
| 5,550 |
| 4,587 |
| 250 |
| 250 |
| 207 |
| 25.95 |
| 4.50 |
| -1,158 |
| 1,453 |
| 0 |
| 295 |
| -0.21 |
| -1.25 |
| - |
| - |
| 4.50 |
| 250 |
| 2025 |
|---|
| 5,550 |
| 4,587 |
| 250 |
| 250 |
| 207 |
| 25.95 |
| 4.50 |
| -1,158 |
| 1,453 |
| 0 |
| 295 |
| -0.21 |
| -1.25 |
| - |
| - |
| 4.50 |
| 250 |
Turnover (€)
2025
Turnover (€)
5,550 €86 % *
Sales per employee (€)
4,587 €53 % *
Profit before tax (€)
250 €129 % *
Net Profit (€)
250 €129 % *
Profit per employee (€)
207 €124 % *
Total profitability (%)
25.95 %-11.82 % *
Net profitability (%)
4.50 %115.38 % *
Equity (€)
-1,158 €18 % *
Amounts Payable And Liabilities (€)
1,453 €-1 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
295 €400 % *
Working capital requirement
-0.21 55.32 % *
Debt-to-equity ratio
-1.25 -20.19 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
4.50 %115.38 % *
EBIT (€)
250 €129 % *
